Author Archive of David

Treatment Updates

Further reports of problems with ANAPEN injectors Having first heard reports of potential problems with ANAPEN injectors in the UK last May, EFA has received news of further concerns, this time from France. EFA’s French member, Association Française pour la Prévention des Allergies (AFPRAL), has said the French drugs agency, Agence nationale de sécurité du médicament et des produits de santé (ANSM), has received reports of defects in the

Read More
Seasonal Member News

Take Care This Christmas! It’s easy to chill out and relax at Christmas and be a little less careful about your allergies. So remember these simple steps to help keep you safe. Tell those around you of your allergies, which is especially important if you are with new friends or family that may not be aware. Remember to keep your medications, such as adrenaline, antihistamines or inhalers, with you at all times.  Don’t tempt fate – check all

Read More
Implementing a National Allergy Programme

EFA publishes report on Finnish Allergy Programme educational meeting in Helsinki During the Finnish Allergy Programme educational meeting in Helsinki, many useful and sometimes surprising lessons were learned about the best ways to raise awareness of a cause and take action when the way forward (and sources of funding!) may not necessarily be clear. The report details how EFA delegations from Italy (Tuscany), Norway and Bulgaria – all of which

Read More
Release of the Tobacco Products Directive

Just before the Christmas break, the European Commission has finally released the long-awaited revision of the tobacco products directive. More than ten years have passed since the adoption of the current directive. During this time, there have been several market, scientific and international developments in the tobacco sector and the existing rules present a number of weaknesses, gaps and loopholes. Therefore, it has become necessary to update

Read More
EFA is Hiring an EU Policy and Programme Intern for 2013!

EFA European Federation of Allergy and Airways Diseases Patients' Associations Is looking for EU Policy and Programme Intern (m/f) to start 2013   EFA is the network of European patient organisations that represents people with allergy, asthma and chronic obstructive pulmonary disease (COPD) at European level. EFA is dedicated in making Europe a place where people with these diseases have the right to best quality of care and safe environment,

Read More
Adopting a New Approach to Allergies, Introducing the Finnish Allergy Program 2008-2018

Helsinki, 8-9 November 2012 - Representatives from the Finnish Allergy Programme (FAP) joined participants from three EFA member delegations visiting Helsinki from Bulgaria, Italy and Norway to educate them on the FAP's origins and successful implementation. The two day  meeting introduced the FAP in a clear and understandable format, while allowing for an opportunity for the delegations to collaborate and brainstorm comparable national programmes

Read More
Welcome to the November eZine!

Hello and welcome to this month’s round-up of EFA activities, updates and news!  This month EFA has been busy writing a position paper on pollen forecasting, submitting a paper to EMA on the involvement of young people in reviewing medicines as well as an open letter to Commission President Barroso calling for the release of the new tobacco products legislation, we report on EFA member activities for World COPD Day, EFA reports from the Finnish

Read More
EFA Pollen Paper

EFA is pleased to announce it has written a position paper on pollen forecasting in Europe. The paper draws attention to the fact that the current economic crisis is threatening the future of European pollen forecasting services, and calls on the EU to take action to prevent this.  EFA position paper calls for legislation to ensure pollen forecasting in Europe EFA has written a position paper on the need to legislate for pollen forecasting in Europe,

Read More
Treatment Updates

In treatment news this November EMA reports on new COPD medicines and a UK body plans do discourage the use of a previously approved asthma drug.    EMA report on newly approved COPD medicines published The European Medicines Agency (EMA) has released European public assessment reports (EPAR) on three COPD medicines for relief of symptoms in adult COPD patients. The medicines, for which approval was issued in September, are Enurev Breezhaler, Tovanor

Read More
Member News

In member news this month, EFA members have told us about their activities to mark World COPD Day 2012, our Finnish members join the bid to make Finland smoke-free by 2040, FFAAIR holds a COPD session and a new asthma iPhone app is launched in Ireland.  World COPD day! EFA members from Austria, Bulgaria, France, Germany, Spain and Sweden all marked World COPD Day in their home countries through a large number of activities. In France FFAAIR reported

Read More
EFA and EU Policy Update

In policy news this month, EFA is pleased to announce we have submitted a paper to EMA calling for increased involvement of children and young people in reviewing medicines that are targeted to them, we have collaborated in sending a letter to President Barroso calling for the speedy release of the new tobacco products legislation, a new EU health Commissioner has been appointed, Cyprus has organised a debate on respiratory diseases and healthy aging

Read More
EFA in Meetings

This month EFA reports from the education meeting it co-hosted in Helsinki  on the Finnish Allergy Programme, from a lunchtime debate in the European Parliament on Healthy Ageing with Respiratory Disease, from a conference on telemedicines in Germany and more.    EFA and the Finnish Allergy and Asthma Federation co-host first Finnish Allergy Programme Educational Meeting in Helsinki On the 8th and 9th of November, representatives of the Finnish

Read More

EFA eZine Archive